General Information of Target

Target ID LDTP07907
Target Name Tubulin alpha-1A chain (TUBA1A)
Gene Name TUBA1A
Gene ID 7846
Synonyms
TUBA3; Tubulin alpha-1A chain; EC 3.6.5.-; Alpha-tubulin 3; Tubulin B-alpha-1; Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MRECISIHVGQAGVQIGNACWELYCLEHGIQPDGQMPSDKTIGGGDDSFNTFFSETGAGK
HVPRAVFVDLEPTVIDEVRTGTYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDLVLD
RIRKLADQCTGLQGFLVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTA
VVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLIGQIVSSITA
SLRFDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLSVAEITNACFEPAN
QMVKCDPRHGKYMACCLLYRGDVVPKDVNAAIATIKTKRTIQFVDWCPTGFKVGINYQPP
TVVPGGDLAKVQRAVCMLSNTTAIAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSE
AREDMAALEKDYEEVGVDSVEGEGEEEGEEY
Target Bioclass
Enzyme
Family
Tubulin family
Subcellular location
Cytoplasm, cytoskeleton
Function
Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin.
Uniprot ID
Q71U36
Ensemble ID
ENST00000295766.9
HGNC ID
HGNC:20766
ChEMBL ID
CHEMBL3661

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
HGC27 SNV: p.R339H DBIA    Probe Info 
HT3 SNV: p.Q358Ter .
NCIH1155 SNV: p.R402H .
SUPT1 SNV: p.A99V .

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 39 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
m-APA
 Probe Info 
15.00  LDD0402  [1]
DAyne
 Probe Info 
2.86  LDD0261  [2]
N1
 Probe Info 
4.71  LDD0242  [3]
TH211
 Probe Info 
Y357(10.79)  LDD0257  [4]
TH216
 Probe Info 
Y357(8.28)  LDD0259  [4]
Nap-2
 Probe Info 
N.A.  LDD0435  [5]
AZ-9
 Probe Info 
D46(1.01); D47(1.01); D345(1.11); E386(1.02)  LDD2208  [6]
OPA-S-S-alkyne
 Probe Info 
K338(2.00); K336(2.00)  LDD3494  [7]
P26
 Probe Info 
1.71  LDD0409  [8]
JZ128-DTB
 Probe Info 
C4(0.00); C347(0.00); C200(0.00)  LDD0462  [9]
AHL-Pu-1
 Probe Info 
C295(7.28)  LDD0170  [10]
EA-probe
 Probe Info 
C4(1.11); C129(1.04); C347(0.98); C129(1.08)  LDD2210  [11]
HHS-482
 Probe Info 
Y103(0.88); Y108(0.87); Y161(0.88); Y224(0.87)  LDD0285  [12]
HHS-475
 Probe Info 
Y408(0.57); Y103(0.64); Y399(0.65); Y262(0.67)  LDD0264  [13]
HHS-465
 Probe Info 
Y103(10.00); Y108(10.00); Y161(7.71); Y224(10.00)  LDD2237  [14]
DBIA
 Probe Info 
C295(0.98)  LDD0078  [15]
ATP probe
 Probe Info 
N.A.  LDD0199  [16]
4-Iodoacetamidophenylacetylene
 Probe Info 
N.A.  LDD0038  [17]
IA-alkyne
 Probe Info 
N.A.  LDD0036  [17]
IPIAA_L
 Probe Info 
C376(0.00); C200(0.00); C20(0.00); C295(0.00)  LDD0031  [18]
Lodoacetamide azide
 Probe Info 
N.A.  LDD0037  [17]
BTD
 Probe Info 
N.A.  LDD0004  [19]
JW-RF-010
 Probe Info 
C315(0.00); C305(0.00); C376(0.00); C295(0.00)  LDD0026  [20]
NAIA_4
 Probe Info 
N.A.  LDD2226  [21]
NAIA_5
 Probe Info 
N.A.  LDD2224  [21]
WYneN
 Probe Info 
C295(0.00); C347(0.00); C376(0.00)  LDD0021  [19]
1d-yne
 Probe Info 
K60(0.00); K96(0.00)  LDD0356  [22]
Compound 10
 Probe Info 
N.A.  LDD2216  [23]
Compound 11
 Probe Info 
N.A.  LDD2213  [23]
ENE
 Probe Info 
N.A.  LDD0006  [19]
IPM
 Probe Info 
N.A.  LDD2156  [24]
OSF
 Probe Info 
Y357(0.00); Y108(0.00); Y224(0.00); H107(0.00)  LDD0029  [25]
PF-06672131
 Probe Info 
N.A.  LDD0152  [26]
SF
 Probe Info 
Y408(0.00); Y262(0.00); K60(0.00); K338(0.00)  LDD0028  [25]
STPyne
 Probe Info 
K60(0.00); K352(0.00); K401(0.00); K304(0.00)  LDD0009  [19]
Phosphinate-6
 Probe Info 
C315(0.00); C347(0.00); C25(0.00); C305(0.00)  LDD0018  [27]
Ox-W18
 Probe Info 
N.A.  LDD2175  [28]
1c-yne
 Probe Info 
K96(0.00); C20(0.00); K352(0.00); K280(0.00)  LDD0228  [22]
AOyne
 Probe Info 
15.00  LDD0443  [29]
PAL-AfBPP Probe
Click To Hide/Show 13 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
FFF probe12
 Probe Info 
6.81  LDD0473  [30]
FFF probe13
 Probe Info 
9.78  LDD0475  [30]
FFF probe2
 Probe Info 
5.21  LDD0463  [30]
FFF probe3
 Probe Info 
5.02  LDD0464  [30]
FFF probe4
 Probe Info 
6.94  LDD0466  [30]
STS-2
 Probe Info 
1.85  LDD0138  [31]
A-DA
 Probe Info 
2.53  LDD0143  [32]
BD-F
 Probe Info 
E77(0.00); E71(0.00); I75(0.00); R79(0.00)  LDD0024  [33]
TM-F
 Probe Info 
E71(0.00); V68(0.00); D76(0.00)  LDD0020  [33]
Photocelecoxib
 Probe Info 
F53(0.00); V68(0.00); D69(0.00); P72(0.00)  LDD0019  [34]
Photoindomethacin
 Probe Info 
E71(0.00); V68(0.00); K370(0.00)  LDD0155  [34]
DA-2
 Probe Info 
N.A.  LDD0070  [35]
STS-1
 Probe Info 
N.A.  LDD0068  [36]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0025  4SU-RNA DM93 C295(7.28)  LDD0170  [10]
 LDCM0156  Aniline NCI-H1299 11.53  LDD0403  [1]
 LDCM0020  ARS-1620 HCC44 C295(0.98)  LDD0078  [15]
 LDCM0083  Avasimibe A-549 2.53  LDD0143  [32]
 LDCM0632  CL-Sc Hep-G2 C347(3.33); C347(0.99)  LDD2227  [21]
 LDCM0634  CY-0357 Hep-G2 C347(0.79)  LDD2228  [21]
 LDCM0175  Ethacrynic acid HeLa C4(1.11); C129(1.04); C347(0.98); C129(1.08)  LDD2210  [11]
 LDCM0625  F8 Ramos C305(2.16); 1.08; C347(1.49); C376(0.35)  LDD2187  [37]
 LDCM0572  Fragment10 MDA-MB-231 C347(2.19); C376(2.67); C129(1.65)  LDD1389  [38]
 LDCM0573  Fragment11 MDA-MB-231 C347(1.68); C376(1.83); C129(1.15)  LDD1391  [38]
 LDCM0574  Fragment12 MDA-MB-231 C347(3.38); C376(3.67); C129(2.80)  LDD1393  [38]
 LDCM0575  Fragment13 MDA-MB-231 C347(1.08); C376(1.18)  LDD1395  [38]
 LDCM0576  Fragment14 MDA-MB-231 C347(1.93); C376(2.31); C129(1.81)  LDD1397  [38]
 LDCM0577  Fragment15 MDA-MB-231 C347(2.19); C376(4.05); C129(2.25)  LDD1399  [38]
 LDCM0579  Fragment20 MDA-MB-231 C347(4.61); C376(6.14); C129(3.66)  LDD1402  [38]
 LDCM0580  Fragment21 MDA-MB-231 C347(1.22); C376(1.48); C129(1.09)  LDD1404  [38]
 LDCM0581  Fragment22 MDA-MB-231 C347(1.27); C376(1.38)  LDD1406  [38]
 LDCM0582  Fragment23 MDA-MB-231 C347(2.91); C376(2.75); C129(3.55)  LDD1408  [38]
 LDCM0583  Fragment24 Ramos C347(1.76); C376(1.60); C129(1.71)  LDD1410  [38]
 LDCM0584  Fragment25 MDA-MB-231 C347(0.88); C376(0.86); C129(0.95)  LDD1411  [38]
 LDCM0585  Fragment26 Ramos C347(1.10); C376(0.92); C129(0.88)  LDD1412  [38]
 LDCM0578  Fragment27 MDA-MB-231 C347(0.92); C376(0.89); C129(0.98)  LDD1401  [38]
 LDCM0586  Fragment28 MDA-MB-231 C347(1.00); C376(1.12); C129(0.99)  LDD1415  [38]
 LDCM0587  Fragment29 MDA-MB-231 C347(1.32); C376(1.33); C129(1.13)  LDD1417  [38]
 LDCM0588  Fragment30 MDA-MB-231 C347(1.01); C376(1.11); C129(0.88)  LDD1419  [38]
 LDCM0589  Fragment31 MDA-MB-231 C347(1.71); C376(2.51); C129(2.22)  LDD1421  [38]
 LDCM0590  Fragment32 MDA-MB-231 C347(2.79); C376(3.94); C129(1.65)  LDD1423  [38]
 LDCM0468  Fragment33 MDA-MB-231 C347(1.00); C376(1.07)  LDD1425  [38]
 LDCM0592  Fragment34 MDA-MB-231 C347(0.88); C376(1.03); C129(1.04)  LDD1427  [38]
 LDCM0593  Fragment35 MDA-MB-231 C347(0.84); C376(0.87); C129(1.00)  LDD1429  [38]
 LDCM0594  Fragment36 MDA-MB-231 C347(1.66); C376(1.79); C129(1.44)  LDD1431  [38]
 LDCM0595  Fragment37 Ramos C347(0.91); C376(0.95)  LDD1432  [38]
 LDCM0596  Fragment38 MDA-MB-231 C347(1.13); C376(1.19); C129(1.13)  LDD1433  [38]
 LDCM0597  Fragment39 MDA-MB-231 C347(1.69); C376(2.36); C129(1.04)  LDD1435  [38]
 LDCM0566  Fragment4 MDA-MB-231 C347(2.11); C376(3.67); C129(2.13)  LDD1378  [38]
 LDCM0598  Fragment40 MDA-MB-231 C347(0.84); C376(0.89); C129(0.91)  LDD1436  [38]
 LDCM0599  Fragment41 MDA-MB-231 C347(1.44); C376(1.48); C129(1.21)  LDD1438  [38]
 LDCM0600  Fragment42 Ramos C347(1.14); C376(0.94); C129(0.94)  LDD1440  [38]
 LDCM0601  Fragment43 MDA-MB-231 C347(2.55); C376(2.73); C129(1.36)  LDD1441  [38]
 LDCM0602  Fragment44 MDA-MB-231 C347(0.80); C376(0.81); C129(0.90)  LDD1443  [38]
 LDCM0603  Fragment45 MDA-MB-231 C347(2.78); C376(3.49); C129(2.45)  LDD1444  [38]
 LDCM0604  Fragment46 MDA-MB-231 C347(0.99); C376(1.11); C129(0.93)  LDD1445  [38]
 LDCM0605  Fragment47 MDA-MB-231 C347(1.28); C376(1.33); C129(1.25)  LDD1446  [38]
 LDCM0606  Fragment48 MDA-MB-231 C347(1.14); C376(1.13); C129(1.13)  LDD1447  [38]
 LDCM0607  Fragment49 MDA-MB-231 C347(3.25); C376(4.95)  LDD1448  [38]
 LDCM0608  Fragment50 MDA-MB-231 C347(2.44); C376(3.66); C129(2.21)  LDD1449  [38]
 LDCM0427  Fragment51 MDA-MB-231 C347(0.84); C376(0.97)  LDD1450  [38]
 LDCM0610  Fragment52 MDA-MB-231 C347(1.52); C376(1.54); C129(1.17)  LDD1452  [38]
 LDCM0611  Fragment53 MDA-MB-231 C347(0.97); C376(1.19); C129(1.27)  LDD1454  [38]
 LDCM0612  Fragment54 MDA-MB-231 C347(1.10); C376(1.15)  LDD1456  [38]
 LDCM0613  Fragment55 MDA-MB-231 C347(1.01); C376(1.19)  LDD1457  [38]
 LDCM0614  Fragment56 MDA-MB-231 C347(1.21); C376(1.21); C129(1.23)  LDD1458  [38]
 LDCM0568  Fragment6 MDA-MB-231 C347(1.27); C376(1.22); C129(1.23)  LDD1382  [38]
 LDCM0569  Fragment7 MDA-MB-231 C347(1.96); C376(2.40); C129(1.65)  LDD1383  [38]
 LDCM0570  Fragment8 MDA-MB-231 C347(1.95); C376(2.08); C129(1.51)  LDD1385  [38]
 LDCM0571  Fragment9 MDA-MB-231 C347(1.73); C376(2.46); C129(1.67)  LDD1387  [38]
 LDCM0116  HHS-0101 DM93 Y408(0.57); Y103(0.64); Y399(0.65); Y262(0.67)  LDD0264  [13]
 LDCM0117  HHS-0201 DM93 Y399(0.53); Y161(0.53); Y103(0.60); Y312(0.60)  LDD0265  [13]
 LDCM0118  HHS-0301 DM93 Y312(0.52); Y262(0.52); Y399(0.61); Y272(0.64)  LDD0266  [13]
 LDCM0119  HHS-0401 DM93 Y272(0.39); Y312(0.42); Y262(0.44); Y399(0.49)  LDD0267  [13]
 LDCM0120  HHS-0701 DM93 Y103(0.40); Y272(0.47); Y262(0.52); Y312(0.53)  LDD0268  [13]
 LDCM0015  HNE MDA-MB-231 C347(0.88)  LDD0346  [37]
 LDCM0123  JWB131 DM93 Y103(0.88); Y108(0.87); Y161(0.88); Y224(0.87)  LDD0285  [12]
 LDCM0124  JWB142 DM93 Y103(0.60); Y108(0.59); Y161(0.60); Y224(0.61)  LDD0286  [12]
 LDCM0125  JWB146 DM93 Y103(1.12); Y108(1.13); Y161(1.08); Y224(1.11)  LDD0287  [12]
 LDCM0126  JWB150 DM93 Y103(2.30); Y108(2.21); Y161(2.31); Y224(2.46)  LDD0288  [12]
 LDCM0127  JWB152 DM93 Y103(1.74); Y108(1.71); Y161(1.62); Y224(1.83)  LDD0289  [12]
 LDCM0128  JWB198 DM93 Y103(1.06); Y108(1.06); Y161(1.04); Y224(1.02)  LDD0290  [12]
 LDCM0129  JWB202 DM93 Y103(0.39); Y108(0.39); Y161(0.37); Y224(0.43)  LDD0291  [12]
 LDCM0130  JWB211 DM93 Y103(0.91); Y108(0.89); Y161(0.90); Y224(0.89)  LDD0292  [12]
 LDCM0179  JZ128 PC-3 C4(0.00); C347(0.00); C200(0.00)  LDD0462  [9]
 LDCM0022  KB02 HCT 116 C347(1.63)  LDD0080  [15]
 LDCM0023  KB03 HCT 116 C347(3.44)  LDD0081  [15]
 LDCM0024  KB05 HCT 116 C347(1.67)  LDD0082  [15]
 LDCM0159  P28 BxPC-3 1.71  LDD0409  [8]
 LDCM0021  THZ1 HCT 116 C315(1.19); C316(1.19); C295(1.23); C305(1.23)  LDD2173  [15]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Enzyme
Click To Hide/Show 3 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Ubiquitin carboxyl-terminal hydrolase CYLD (CYLD) Peptidase C19 family Q9NQC7
Epidermal growth factor receptor (EGFR) Tyr protein kinase family P00533
Tubulin alpha-1A chain (TUBA1A) Tubulin family Q71U36
Transporter and channel
Click To Hide/Show 2 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Amyloid-beta precursor protein (APP) APP family P05067
Huntingtin (HTT) Huntingtin family P42858
Transcription factor
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Transcription factor Jun (JUN) BZIP family P05412
Other
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Tubulin beta chain (TUBB) Tubulin family P07437

The Drug(s) Related To This Target

Approved
Click To Hide/Show 5 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Albendazole Small molecular drug DB00518
Mebendazole Small molecular drug DB00643
Vinblastine Small molecular drug DB00570
Artenimol . DB11638
Colchiceine . DB15534
Investigative
Click To Hide/Show 5 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Epothilone D Small molecular drug DB01873
Patupilone Small molecular drug DB03010
Phenethyl Isothiocyanate Small molecular drug DB12695
2-mercapto-n-[12310-tetramethoxy-9-oxo-5679-tetrahydro-benzo[A]Heptalen-7-yl]Acetamide . DB07574
Cyt997 . DB05147

References

1 Quantitative and Site-Specific Chemoproteomic Profiling of Targets of Acrolein. Chem Res Toxicol. 2019 Mar 18;32(3):467-473. doi: 10.1021/acs.chemrestox.8b00343. Epub 2019 Jan 15.
2 Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine. ACS Chem Biol. 2021 Nov 19;16(11):2581-2594. doi: 10.1021/acschembio.1c00629. Epub 2021 Nov 2.
3 Cyclopropenone, Cyclopropeniminium Ion, and Cyclopropenethione as Novel Electrophilic Warheads for Potential Target Discovery of Triple-Negative Breast Cancer. J Med Chem. 2023 Feb 23;66(4):2851-2864. doi: 10.1021/acs.jmedchem.2c01889. Epub 2023 Feb 10.
4 Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes. Chem Sci. 2021 Jan 21;12(9):3295-3307. doi: 10.1039/d0sc06623k.
5 Proteome-Wide Identification of On- and Off-Targets of Bcl-2 Inhibitors in Native Biological Systems by Using Affinity-Based Probes (AfBPs). Chembiochem. 2018 Nov 2;19(21):2312-2320. doi: 10.1002/cbic.201800380. Epub 2018 Oct 18.
6 2H-Azirine-Based Reagents for Chemoselective Bioconjugation at Carboxyl Residues Inside Live Cells. J Am Chem Soc. 2020 Apr 1;142(13):6051-6059. doi: 10.1021/jacs.9b12116. Epub 2020 Mar 23.
7 A chemical proteomics approach for global mapping of functional lysines on cell surface of living cell. Nat Commun. 2024 Apr 8;15(1):2997. doi: 10.1038/s41467-024-47033-w.
Mass spectrometry data entry: PXD042888
8 Integrated phenotypic screening and activity-based protein profiling to reveal potential therapy targets of pancreatic cancer. Chem Commun (Camb). 2019 Jan 31;55(11):1596-1599. doi: 10.1039/c8cc08753a.
9 A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification. J Am Chem Soc. 2019 Jan 9;141(1):191-203. doi: 10.1021/jacs.8b07911. Epub 2018 Dec 20.
10 Chemoproteomic capture of RNA binding activity in living cells. Nat Commun. 2023 Oct 7;14(1):6282. doi: 10.1038/s41467-023-41844-z.
Mass spectrometry data entry: PXD044625
11 Chemoproteomic Profiling Reveals Ethacrynic Acid Targets Adenine Nucleotide Translocases to Impair Mitochondrial Function. Mol Pharm. 2018 Jun 4;15(6):2413-2422. doi: 10.1021/acs.molpharmaceut.8b00250. Epub 2018 May 15.
12 Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes. Chem Sci. 2021 Jan 21;12(9):3295-3307. doi: 10.1039/d0sc06623k.
13 Discovery of a Cell-Active SuTEx Ligand of Prostaglandin Reductase 2. Chembiochem. 2021 Jun 15;22(12):2134-2139. doi: 10.1002/cbic.202000879. Epub 2021 Apr 29.
14 Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat Chem Biol. 2020 Feb;16(2):150-159. doi: 10.1038/s41589-019-0404-5. Epub 2019 Nov 25.
15 Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May;39(5):630-641. doi: 10.1038/s41587-020-00778-3. Epub 2021 Jan 4.
16 Targeted Proteomic Approaches for Proteome-Wide Characterizations of the AMP-Binding Capacities of Kinases. J Proteome Res. 2022 Aug 5;21(8):2063-2070. doi: 10.1021/acs.jproteome.2c00225. Epub 2022 Jul 12.
17 Enhancing Cysteine Chemoproteomic Coverage through Systematic Assessment of Click Chemistry Product Fragmentation. Anal Chem. 2022 Mar 8;94(9):3800-3810. doi: 10.1021/acs.analchem.1c04402. Epub 2022 Feb 23.
Mass spectrometry data entry: PXD028853
18 SP3-Enabled Rapid and High Coverage Chemoproteomic Identification of Cell-State-Dependent Redox-Sensitive Cysteines. Mol Cell Proteomics. 2022 Apr;21(4):100218. doi: 10.1016/j.mcpro.2022.100218. Epub 2022 Feb 25.
Mass spectrometry data entry: PXD029500 , PXD031647
19 A modification-centric assessment tool for the performance of chemoproteomic probes. Nat Chem Biol. 2022 Aug;18(8):904-912. doi: 10.1038/s41589-022-01074-8. Epub 2022 Jul 21.
Mass spectrometry data entry: PXD027758 , PXD027755 , PXD027760 , PXD027762 , PXD027756 , PXD027591 , PXD007149 , PXD030064 , PXD032392 , PXD027789 , PXD027767 , PXD027764
20 Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals Myrocin G as an Inhibitor of the Nonhomologous End Joining DNA Repair Pathway. J Am Chem Soc. 2021 Dec 8;143(48):20332-20342. doi: 10.1021/jacs.1c09724. Epub 2021 Nov 24.
Mass spectrometry data entry: PXD029255
21 N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics. Nat Commun. 2023 Jun 15;14(1):3564. doi: 10.1038/s41467-023-39268-w.
Mass spectrometry data entry: PXD041264
22 Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine. Angew Chem Int Ed Engl. 2022 Jan 26;61(5):e202112107. doi: 10.1002/anie.202112107. Epub 2021 Dec 16.
23 Multiplexed CuAAC Suzuki-Miyaura Labeling for Tandem Activity-Based Chemoproteomic Profiling. Anal Chem. 2021 Feb 2;93(4):2610-2618. doi: 10.1021/acs.analchem.0c04726. Epub 2021 Jan 20.
Mass spectrometry data entry: PXD022279
24 Benchmarking Cleavable Biotin Tags for Peptide-Centric Chemoproteomics. J Proteome Res. 2022 May 6;21(5):1349-1358. doi: 10.1021/acs.jproteome.2c00174. Epub 2022 Apr 25.
Mass spectrometry data entry: PXD031019
25 Solid Phase Synthesis of Fluorosulfate Containing Macrocycles for Chemoproteomic Workflows. bioRxiv [Preprint]. 2023 Feb 18:2023.02.17.529022. doi: 10.1101/2023.02.17.529022.
Mass spectrometry data entry: PXD039931
26 Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles. Mol Cell Proteomics. 2023 Jan;22(1):100455. doi: 10.1016/j.mcpro.2022.100455. Epub 2022 Nov 24.
Mass spectrometry data entry: PXD036569
27 DFT-Guided Discovery of Ethynyl-Triazolyl-Phosphinates as Modular Electrophiles for Chemoselective Cysteine Bioconjugation and Profiling. Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202205348. doi: 10.1002/anie.202205348. Epub 2022 Aug 22.
Mass spectrometry data entry: PXD033004
28 Oxidative cyclization reagents reveal tryptophan cation- interactions. Nature. 2024 Mar;627(8004):680-687. doi: 10.1038/s41586-024-07140-6. Epub 2024 Mar 6.
Mass spectrometry data entry: PXD001377 , PXD005252
29 Chemoproteomic profiling of targets of lipid-derived electrophiles by bioorthogonal aminooxy probe. Redox Biol. 2017 Aug;12:712-718. doi: 10.1016/j.redox.2017.04.001. Epub 2017 Apr 5.
30 Ligand and Target Discovery by Fragment-Based Screening in Human Cells. Cell. 2017 Jan 26;168(3):527-541.e29. doi: 10.1016/j.cell.2016.12.029. Epub 2017 Jan 19.
31 Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling. Angew Chem Int Ed Engl. 2013 Aug 12;52(33):8551-6. doi: 10.1002/anie.201300683. Epub 2013 Jun 10.
32 A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells. Cell. 2015 Jun 18;161(7):1668-80. doi: 10.1016/j.cell.2015.05.045.
33 Evaluation of fully-functionalized diazirine tags for chemical proteomic applications. Chem Sci. 2021 May 7;12(22):7839-7847. doi: 10.1039/d1sc01360b.
Mass spectrometry data entry: PXD025652
34 Small Molecule Interactome Mapping by Photoaffinity Labeling Reveals Binding Site Hotspots for the NSAIDs. J Am Chem Soc. 2018 Mar 28;140(12):4259-4268. doi: 10.1021/jacs.7b11639. Epub 2018 Mar 15.
Mass spectrometry data entry: PXD007094
35 Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. J Am Chem Soc. 2012 Feb 15;134(6):3001-14. doi: 10.1021/ja208518u. Epub 2012 Feb 1.
36 Proteome profiling reveals potential cellular targets of staurosporine using a clickable cell-permeable probe. Chem Commun (Camb). 2011 Oct 28;47(40):11306-8. doi: 10.1039/c1cc14824a. Epub 2011 Sep 16.
37 Site-specific quantitative cysteine profiling with data-independent acquisition-based mass spectrometry. Methods Enzymol. 2023;679:295-322. doi: 10.1016/bs.mie.2022.07.037. Epub 2022 Sep 7.
Mass spectrometry data entry: PXD027578
38 Proteome-wide covalent ligand discovery in native biological systems. Nature. 2016 Jun 23;534(7608):570-4. doi: 10.1038/nature18002. Epub 2016 Jun 15.